Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Y Spiegel

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Ejhaem|July 18, 2022
Imagining the cell therapist: Future CAR T cell monitoring and intervention strategies to improve patient outcomesMichael D Jain, Jay Y Spiegel
Blood|February 17, 2022
Treating CAR-T relapses: check not checkmateJay Y Spiegel, Krishna V Komanduri
JAMA Oncology|December 12, 2024
Second Primary Cancer After Chimeric Antigen Receptor-T-Cell Therapy: A ReviewShyam A Patel, Jay Y Spiegel, Saurabh Dahiya
Leukemia & Lymphoma|May 17, 2016
Validation of the NCCN-IPI in both de novo and transformed diffuse large B cell lymphomaJay Y Spiegel, Matthew C Cheung, Hany R Guirguis, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2018
A phase I study of intravenous artesunate in patients with advanced solid tumor malignanciesJohn F Deeken, Hongkun Wang, Marion Hartley, et al.
The Lancet. Haematology|December 11, 2024
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trialJuan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, et al.
Blood Advances|January 4, 2018
Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapyJay Y Spiegel, Caroline McNamara, James A Kennedy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional TrialMatthew J Frank, Nasheed M Hossain, Ali Bukhari, et al.
Blood Advances|August 23, 2021
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemiaLori Muffly, Vandana Sundaram, Connie Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPETFederico Simonetta, Israt S Alam, Juliane K Lohmeyer, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Ejhaem|July 18, 2022
Imagining the cell therapist: Future CAR T cell monitoring and intervention strategies to improve patient outcomesMichael D Jain, Jay Y Spiegel
Blood|February 17, 2022
Treating CAR-T relapses: check not checkmateJay Y Spiegel, Krishna V Komanduri
JAMA Oncology|December 12, 2024
Second Primary Cancer After Chimeric Antigen Receptor-T-Cell Therapy: A ReviewShyam A Patel, Jay Y Spiegel, Saurabh Dahiya
Leukemia & Lymphoma|May 17, 2016
Validation of the NCCN-IPI in both de novo and transformed diffuse large B cell lymphomaJay Y Spiegel, Matthew C Cheung, Hany R Guirguis, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2018
A phase I study of intravenous artesunate in patients with advanced solid tumor malignanciesJohn F Deeken, Hongkun Wang, Marion Hartley, et al.
The Lancet. Haematology|December 11, 2024
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trialJuan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, et al.
Blood Advances|January 4, 2018
Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapyJay Y Spiegel, Caroline McNamara, James A Kennedy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional TrialMatthew J Frank, Nasheed M Hossain, Ali Bukhari, et al.
Blood Advances|August 23, 2021
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemiaLori Muffly, Vandana Sundaram, Connie Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPETFederico Simonetta, Israt S Alam, Juliane K Lohmeyer, et al.
Pageof 3